Rituximab (RTX) Therapy in Patients With Active TAO

Clinical trial NCT02378298 · COMPLETED

Trial details

NCT number: NCT02378298
Sponsor: Göteborg University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Ophthalmopathy, Thyroid-Associated

Start date: 2011-12-01
Primary completion: 2019-09-03
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.